Drug Stocks In News: Auxilium Pharmaceuticals (NASDAQ:AUXL), USANA Health Sciences (NYSE:USNA), Pro Phase Labs (NASDAQ:PRPH), Life Vantage (NASDAQ:LFVN)

Auxilium Pharmaceuticals Inc. was hit with a second lawsuit within a week in Pennsylvania court over its testosterone-boosting gel Testim, when a man on Friday contended that the use of the drug led to a heart attack. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) shares after opening at $27.70  moved to $28.01 on last trade day and at the end of the day closed at $26.51. Company price to sales ratio in past twelve months was calculated as 3.29 and price to cash ratio as 18.55. Auxilium Pharmaceuticals, Inc.(NASDAQ:AUXL)showed a negative weekly performance of -11.57%.

Being viewed is as pyramid schemes hurts stock of multi-level companies like USANA Health Sciences, Inc. (NYSE:USNA). A lot of negative things have been associated with pyramid schemes that authorities across the world are always on high alert and stern eye on tier marketing companies. But the latest development in China where investigations into the business practice of a multi-level company ended with a much smaller fine than expected comes as a big morale boost for managers of direct-sales companies like USANA Health Sciences, Inc. (NYSE:USNA). USANA Health Sciences, Inc. (NYSE:USNA) shares advanced0.34% in last trading session and ended the day on $74.02.USNA  return on equity ratio is recorded as 35.10% and its return on assets is 25.00%. USANA Health Sciences, Inc. (NYSE:USNA) yearly performance is 53.16%.

Shares of Pro Phase Labs Inc (NASDAQ:PRPH), which markets Cold-EEZE Cold Remedy brand as well as other cold relief products, rose more than 5% to $2 on Thursday, following the company’s financial report for fiscal 2013, which represents its first profitable fiscal year since 2005. Pro Phase Labs Inc (NASDAQ:PRPH) shares moved up 0.98% in last trading session and was closed at $2.02, while trading in range of $2.00 – 2.14. Pro Phase Labs Inc (NASDAQ:PRPH) year to date (YTD) performance is 25.44%.

On March 26, 2014, Life Vantage Corp (NASDAQ:LFVN) entered into an Amended and Restated Employment Agreement (the “Agreement”) with Douglas C. Robinson (“Mr. Robinson”). The Agreement supersedes in its entirety Mr. Robinson’s prior employment agreement dated effective as of March 15, 2011 (the “Prior Agreement”). The Prior Agreement would have automatically terminated on June 30, 2014 in accordance with its terms. The Agreement, which is primarily consistent with the Prior Agreement, was effective on March 25, 2014 and will automatically terminate on June 30, 2016 unless extended by mutual written consent of the Company and Mr. Robinson. Life Vantage Corp (NASDAQ:LFVN) weeklyperformance is -2.94%. On last trading day company shares ended up $1.32. Life Vantage Corp (NASDAQ:LFVN) distance from 50-day simple moving average (SMA50) is -6.26%. Analysts mean target price for the company is $2.10.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *